Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Sep;29(9):5063-5072.
doi: 10.1007/s00330-019-06029-7. Epub 2019 Feb 22.

Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function

F Rassam  1 , T Zhang  2 , K P Cieslak  3 , C Lavini  4 , J Stoker  4 , R J Bennink  4 , T M van Gulik  3 , L J van Vliet  2 , J H Runge  4 , F M Vos  2   4
Affiliations
Observational Study

Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function

F Rassam et al. Eur Radiol. 2019 Sep.

Abstract

Objectives: To compare Gd-EOB-DTPA dynamic hepatocyte-specific contrast-enhanced MRI (DHCE-MRI) with 99mTc-mebrofenin hepatobiliary scintigraphy (HBS) as quantitative liver function tests for the preoperative assessment of patients undergoing liver resection.

Methods: Patients undergoing liver surgery and preoperative assessment of future remnant liver (FRL) function using 99mTc-mebrofenin HBS were included. Patients underwent DHCE-MRI. Total liver uptake function was calculated for both modalities: mebrofenin uptake rate (MUR) and Ki respectively. The FRL was delineated with both SPECT-CT and MRI to calculate the functional share. Blood samples were taken to assess biochemical liver parameters.

Results: A total of 20 patients were included. The HBS-derived MUR and the DHCE-MRI-derived mean Ki correlated strongly for both total and FRL function (Pearson r = 0.70, p = 0.001 and r = 0.89, p < 0.001 respectively). There was a strong agreement between the functional share determined with both modalities (ICC = 0.944, 95% CI 0.863-0.978, n = 20). There was a significant negative correlation between liver aminotransferases and bilirubin for both MUR and Ki.

Conclusions: Assessment of liver function with DHCE-MRI is comparable with that of 99mTc-mebrofenin HBS and has the potential to be combined with diagnostic MRI imaging. This can therefore provide a one-stop-shop modality for the preoperative assessment of patients undergoing liver surgery.

Key points: • Quantitative assessment of liver function using hepatobiliary scintigraphy is performed in the preoperative assessment of patients undergoing liver surgery in order to prevent posthepatectomy liver failure. • Gd-EOB-DTPA dynamic hepatocyte-specific contrast-enhanced MRI (DHCE-MRI) is an emerging method to quantify liver function and can serve as a potential alternative to hepatobiliary scintigraphy. • Assessment of liver function with dynamic gadoxetate-enhanced MRI is comparable with that of hepatobiliary scintigraphy and has the potential to be combined with diagnostic MRI imaging.

Keywords: Gadolinium ethoxybenzyl DTPA; Liver function tests; Magnetic resonance imaging; Technetium Tc 99m mebrofenin.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Figures

Fig. 1
Fig. 1
Hepatobiliary scintigraphy with series scintigram (a), ROI on summed images (b), and FRL delineation on SPECT/CT (c)
Fig. 2
Fig. 2
DHCE-MRI protocol
Fig. 3
Fig. 3
Signal intensity curve with semi-quantitative parameters
Fig. 4
Fig. 4
Pearson correlation between total liver function represented by the mebrofenin uptake rate (MUR; %/min) and the Gd-EOB-DTPA uptake rate (Ki; min−1)
Fig. 5
Fig. 5
Bland-Altman plot for the agreement between functional share (%) of the FRL measured with SPECT and MRI
Fig. 6
Fig. 6
Pearson correlation between future remnant liver function represented by the mebrofenin uptake rate (fMUR; %/min) and the Gd-EOB-DTPA uptake rate (fKi; min−1)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253:656–665. doi: 10.1097/SLA.0b013e3181fc08ca. - DOI - PubMed
    1. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406. doi: 10.1097/00000658-200210000-00001. - DOI - PMC - PubMed
    1. van den Broek MA, Olde Damink SW, Dejong CH, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 2008;28:767–780. doi: 10.1111/j.1478-3231.2008.01777.x. - DOI - PubMed
    1. Belghiti J, Hiramatsu K, Benoist S, Massault PP, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection 11. No competing interests declared. J Am Coll Surg. 2000;191:38–46. doi: 10.1016/S1072-7515(00)00261-1. - DOI - PubMed
    1. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–1136. doi: 10.1002/bjs.4202. - DOI - PubMed

Publication types